Litcius/Paper detail

Should biologics for psoriasis be interrupted in the era of COVID-19?

Mark Lebwohl, Ryan Rivera‐Oyola, Dédée F. Murrell

2020Journal of the American Academy of Dermatology154 citationsDOIOpen Access PDF

Topics & Concepts

MedicinePsoriasisPlaceboClinical trialCoronavirus disease 2019 (COVID-19)Internal medicineHydroxychloroquinePandemicImmunologyInfectious disease (medical specialty)DiseaseAlternative medicinePathologyPsoriasis: Treatment and PathogenesisAutoimmune and Inflammatory Disorders ResearchDermatology and Skin Diseases
Should biologics for psoriasis be interrupted in the era of COVID-19? | Litcius